People's United Financial’s Celldex Therapeutics CLDX Stock Holding History

People's United Financial’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-83	Closed	-$3K	–	596
2017 Q2	$3K	Hold	83	–	–	﹤0.01%	990
2017 Q1	$4K	Hold	83	–	–	﹤0.01%	970
2016 Q4	$4K	Hold	83	–	–	﹤0.01%	944
2016 Q3	$5K	Hold	83	–	–	﹤0.01%	791
2016 Q2	$5K	Hold	83	–	–	﹤0.01%	791
2016 Q1	$5K	Hold	83	–	–	﹤0.01%	766
2015 Q4	$20K	Hold	83	–	–	﹤0.01%	657
2015 Q3	$13K	Hold	83	–	–	﹤0.01%	679
2015 Q2	$31K	Hold	83	–	–	﹤0.01%	604
2015 Q1	$35K	Hold	83	–	–	﹤0.01%	592
2014 Q4	$23K	Hold	83	–	–	﹤0.01%	626
2014 Q3	$16K	Hold	83	–	–	﹤0.01%	652
2014 Q2	$20K	Hold	83	–	–	﹤0.01%	645
2014 Q1	$22K	Hold	83	–	–	﹤0.01%	606
2013 Q4	$30K	Hold	83	–	–	﹤0.01%	579
2013 Q3	$44K	Hold	83	–	–	﹤0.01%	529
2013 Q2	$19K	Buy	+83	New	+$16.3K	﹤0.01%	579

Other funds holding CLDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLP Enterprises Branford, Connecticut $1.97M AUM

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

People's United Financial's CLDX Position: Q3 2017 in Review

People's United Financial sold out of Celldex Therapeutics (CLDX) in Q3 2017, closing a stake of 83 shares — an estimated $3K sold.

People's United Financial first reported a position in CLDX in Q2 2013 and held it in 17 quarters. The position peaked at $44K in Q3 2013. 129 funds tracked by Wall St. Rank hold CLDX as of Q3 2017.

People's United Financial reported no remaining Celldex Therapeutics position as of Q3 2017 after selling out during the quarter.
People's United Financial sold 83 Celldex Therapeutics shares in Q3 2017, an estimated $3K.
People's United Financial first reported a position in Celldex Therapeutics in Q2 2013 and held it in 17 quarters.
People's United Financial's Celldex Therapeutics position peaked at $44K in Q3 2013.
129 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2017.

Based on People's United Financial's 13F filing for Q3 2017, filed 13 Nov 2017.